Inflammatory Breast Cancer

Inflammatory breast cancer (IBC) is a rare and aggressive form of breast cancer, accounting for approximately 1-5% of all breast cancer cases in the United States. Unlike other types, IBC often does not present with a distinct lump but rather manifests with symptoms such as redness, swelling, and warmth in the breast. This rapid onset of symptoms is due to cancer cells blocking lymph vessels in the skin of the breast. Diagnosis requires a biopsy to confirm cancerous cells in the skin or breast tissue. Treatment typically involves a multimodal approach including chemotherapy to shrink the tumor, followed by surgery (mastectomy) and radiation therapy to eliminate remaining cancer cells. Targeted therapies and hormone therapy may also be used based on specific tumor characteristics. Early diagnosis and aggressive treatment are crucial due to the rapid progression of IBC, underscoring the importance of awareness and prompt medical attention.

    Related Conference of Inflammatory Breast Cancer

    September 16-17, 2024

    9th World Conference on Breast and Cervical Cancer

    London, UK
    September 19-20, 2024

    25th World Congress on Cancer Summit

    Paris, France
    November 25-26, 2024

    7th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    November 28-29, 2024

    44th Euro Congress on Cancer Science & Therapy

    Paris, France
    November 28-29, 2024

    14th World Congress on Breast Cancer

    Paris, France
    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE
    December 11-12, 2024

    34th Experts Meet On Cancer Research & Therapy

    Paris, France
    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK

    Inflammatory Breast Cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in